Rheumatology 4 Flashcards
Early diffuse Scleroderma with ILD - monitoring regimen?
DLCO - 3 monthly for 3 years then annually
Predictors of Diffuse Scleroderma with ILD?
HRCT = > 20% fibrosis
then
FVC < 70%
Treatment for Diffuse Scleroderma with ILD?
MMF - 1st line
Group I pHTN is idiopathic but what’s the proposed mechanism?
pre-capillary
angioproliferative vasculopathy affects pulmonary ARTERIES - remodelling and RIGHT HEART FAILURE
Group 5 pHTN mechanism?
pulmonary veno-occlusive disease
Characteristic of pre-capillary pHTN (Group 1,3,4) measurement?
mPAP > 20 mmHG
PCWP < 15 mmHG
In systemic Sclerosis - what concurrent disorder confers worst prognosis?
Iron deficiency
Scleroderma renal crisis - risk factors?
If associated with neurologic involvement (headache, visual changes) - what drug?
RNA polymerase III
Tendon friction rubs
IV nitroprusside - to quickly lower HTN
Esophageal and gastric dysmotility in Scleroderma - treatment?
Shortening gastric emptying process, reduce reflux
- Busprirone ( 5-HT1a receptor agonist)
- Masopride (5-HT4 receptor agonist) -
Dermatomyositis has what type of cells?
Inclusion body myositis has what type of cells?
response to treatment?
CD4 T cells
CD4 and CD8 T cells, plasma cells
-less responsive to immunosuppressant
MDA-5 antibodies - significance?
Melanoma differentiation associated gene-5
-HIGH RISK OF ILD
CDAM ( clinically amyopathic dermatomyositis) - clinical significance?
No muscle involvement but malignancy
MDA-5 positive
Antibodies in myositis confers higher risk of malignancy?
Anti-TIF1
Anti-NXP
Antibodies in myositis confers worst prognosis?
antibodies in myositis confers best prognosis?
Anti-SRP/Anti Jo-1
Anti-Mi2
Aspirin suppresses what cytokine in GCA?
IFNy